A Zebrafish Model of Metastatic Colonization Pinpoints Cellular Mechanisms of Circulating Tumor Cell Extravasation

Tyler A Allen1, Mark M Cullen1, Nathan Hawkey1

  • 1Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States.

Frontiers in Oncology
|October 11, 2021
PubMed

Insights

Researchers developed a novel zebrafish model to study cancer metastasis. They found that versican (VCAN) upregulation in extracellular matrix remodeling contributes to osteosarcoma cell extravasation and metastasis.

Area of Science:

  • Comparative oncology
  • Cancer metastasis research
  • Zebrafish models

Background:

  • Metastasis involves multiple complex steps: detachment, migration, invasion, intravasation, circulation, extravasation, and colonization.
  • Studying these individual steps molecularly has been challenging.
  • A comparative oncology approach using zebrafish offers a dynamic model for metastasis research.

Purpose of the Study:

  • To develop a novel experimental framework for studying discrete steps of cancer metastasis.
  • To molecularly profile circulating tumor cell clusters that successfully extravasate.
  • To identify molecular contributors to osteosarcoma metastasis.

Main Methods:

  • Injected canine osteosarcoma cells into transgenic zebrafish with fluorescent blood vessels.
  • Utilized intravital imaging to isolate extravasation-positive tumor cell clusters.
  • Performed RNA-sequencing and systems-level analysis on isolated cell clusters.

Main Results:

  • Extravasated cells showed downregulation of KRAS signaling, immune pathways, and extracellular matrix (ECM) organization.
  • Versican (VCAN) was identified as consistently upregulated within the ECM remodeling pathway.
  • VCAN expression is linked to poorer metastasis-free and overall survival in osteosarcoma patients.

Conclusions:

  • A novel zebrafish model enables the study of specific metastasis steps.
  • Upregulation of versican (VCAN) and dysregulation of the ECM network may drive osteosarcoma metastasis.
  • This study provides a new framework and identifies VCAN as a potential therapeutic target.